Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Facing Down the Lab Assay Patent Monster

PATENT ROYALTIES FOR HOMOCYSTEINE TESTING are the subject of our lead story in this issue. (See pages 2-4.) It provides an early example of how patent-protected diagnostic tests can create budget-busting problems for hospital laboratories which perform those tests. The spectre of crushing royalty payments on a host of patent-protected diagnostic assays has loomed large …

Facing Down the Lab Assay Patent Monster Read More »

To access this post, you must purchase The Dark Report.

Comments

;

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.